Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease

Publisher： Karger

E-ISSN： 1421-9670|44|3|194-203

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.44, Iss.3, 2016-08, pp. : 194-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the Angiotensin II Receptor Antagonist Candesartan Cilexetil on Blood Pressure and Proteinuria in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 385-386

Karger

Access to resources Recommend Favorite

Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 4, 2011-06 ,pp. : 235-244

Karger

Access to resources Recommend Favorite

Dimensions of Arteriovenous Fistulas in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 50-53

Karger

Access to resources Recommend Favorite

Autosomal Dominant Polycystic Kidney Disease – Clinical and Genetic Aspects

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 5, 2002-11 ,pp. : 265-283

Karger

Access to resources Recommend Favorite

Blood Pressure and Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 6, 2014-12 ,pp. : 630-635

Karger

Access to resources Recommend Favorite